Related content

Second-line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: A phase II trial

By Tas Faruk   Demir Cumhur   Camlica Hakan   Ustuner Zeki   Topuz Erkan  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 233-240

Humana Press, Inc

Access to resources Recommend Favorite

Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

By Kalmadi Sujith   McNeill Giles   Davis Mellar   Peereboom David   Adelstein David   Mekhail Tarek  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 507-513

Humana Press, Inc

Access to resources Recommend Favorite

Phase II Trial of Docetaxel in Asian Patients with Inoperable Stage III Non-Small Cell Lung Cancer

By Goh Boon C.   Lehnert Manfred   Lim Hong L.   Ng Alan W. K.   Chan Choong C.   Kong Hwai L.   Lee Soo C.   Wee Joseph   Chua E. T.   Wong John E. L.  

Acta Oncologica, Vol. 39, Iss. 2, 2000-08 ,pp. : 225-229

Informa Healthcare

Access to resources Recommend Favorite

Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer

By Lam Elaine   Au Jessie   Otterson Gregory   Guillaume Wientjes M.   Chen Ling   Shen Tong   Wei Yong   Li Xiaobai   Bekaii-Saab Tanios   Murgo Anthony   Jensen Rhonda   Grever Michael   Villalona-Calero Miguel  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1019-1029

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of weekly docetaxel combined with cisplatin in patients with advanced non-small-cell lung cancer

By Tsunoda Toshiyuki   Koizumi Tomonobu   Hayasaka Muneharu   Hirai Kazuya   Koyama Shigeru   Takabayashi Yasuki   Fujimoto Keisaku   Kubo Keishi  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 2, 2004-08 ,pp. : 173-177

Springer Publishing Company

Access to resources Recommend Favorite